The 2006 American Heart Association Classification of Cardiomyopathies Is the Gold Standard

The cardiomyopathies are an important and complex group of heart muscle diseases with multiple etiologies and heterogeneous phenotypic expression.1 Awareness and knowledge of these diseases in both the public and medical communities have historically been impaired by periodic confusion surrounding definitions and nomenclature. Therefore, formal and systematic classifications have traditionally been viewed as useful exercises promoting greater understanding of the heart muscle diseases.1–10 Indeed, a multitude of such cardiomyopathy classifications have been advanced over the years by individual investigators and consensus panels sanctioned by medically related organizations such as the World Health Organization (WHO).2,4 These classification schemes have evolved in concert with the level of scientific understanding. Response by Elliott p 76 Remarkably, it was not until 50 years ago (1957) that the term cardiomyopathy was used for the first time.1 Over the next 25 years, a number of definitions for cardiomyopathies were advanced. Indeed, in the original 1980 WHO classification,4 cardiomyopathies were defined only as “heart muscle diseases of unknown cause,” reflecting a general lack of available information about basic disease mechanisms. In 1968, the WHO defined cardiomyopathies as “diseases of different and often unknown etiology in which the dominant feature is cardiomegaly and heart failure.”1,3 The final WHO classification published in 19952 proposed “diseases of myocardium associated with cardiac dysfunction” and included for the first time arrhythmogenic right ventricular cardiomyopathy/dysplasia, as well as primary restrictive cardiomyopathy. Therefore, why was it necessary to offer yet another classification scheme for cardiomyopathies in 2006 under the auspices of the American Heart Association (AHA)1? In fact, the international expert consensus panel (and writing group) found several very important reasons to take on this project. The last formal effort at developing a consensus for the classification of cardiomyopathies had been published 12 years previously …

[1]  Robert C. Schlant,et al.  Hurst's the Heart, Arteries and Veins , 1998 .

[2]  W. Abelmann Classification and natural history of primary myocardial disease. , 1984, Progress in cardiovascular diseases.

[3]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[4]  D. Corrado,et al.  Cardiomyopathies: is it time for a molecular classification? , 2004, European heart journal.

[5]  E. Oechslin,et al.  Isolated ventricular non-compaction of the myocardium in adults , 2006, Heart.

[6]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[7]  L. Mestroni,et al.  [Classification of cardiomyopathies]. , 1999, Giornale italiano di cardiologia.

[8]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[9]  G. Burch,et al.  Of classification of cardiomyopathies. , 1975, American heart journal.

[10]  B. Bulkley,et al.  The cardiomyopathies. , 1984, Hospital practice.

[11]  L. McLain,et al.  Sudden death in young athletes. , 2003, Pediatric annals.

[12]  A. Keren,et al.  Assignment of patients into the classification of cardiomyopathies. , 1992, Circulation.

[13]  C. Antzelevitch Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias , 2003, Journal of cardiovascular electrophysiology.

[14]  B. Maron Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[15]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[16]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[17]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[18]  C. Kawai,et al.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. , 1980, British heart journal.

[19]  B. Maron,et al.  Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States , 2005, Circulation.

[20]  Calum A MacRae,et al.  Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[21]  G. Thiene,et al.  The new definition and classification of cardiomyopathies. , 2000, Advances in clinical pathology : the official journal of Adriatic Society of Pathology.